Patients are really the core of our mission. We are committed to studying the individual patient within the broader context of evolving research in order to more precisely define and disrupt the progression of myeloid malignancies. This “N=1 approach” requires a strong alliance between patient and provider, which is fostered by a care team that comprises a great deal of both scientific as well as clinical expertise but in a compassionate setting where intellectual curiosity and openness to new therapeutic and diagnostic possibilities abound.
We continue to build upon our legacy of excellence in patient care. Click here to learn more about the Blood Diseases Center at the USC Norris Comprehensive Cancer Center. If you are a patient seeking care from one of our specialists, call (800) USC-CARE (800-872-2273) or visit https://cancer.keckmedicine.org/request-an-appointment/ to request an appointment.
We are kicking off our Inherited Myeloid Malignancy Program in 2017-2018 which will enable us to evaluate and follow patients with a strong family history of myeloid malignancy. We have already put our expertise to work in this area by identifying new and known genetic defects in families. Our aim is to identify novel ways to treat and prevent progression of disease.